CIK 0000310158
- Large accelerated filer
Merck & Co., Inc.
Sign in to watch- Ticker
- MRK
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 221918501
- Phone
- +1 908-740-4000
- Business address
- 126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
- Former names
- Merck & Co. Inc., SCHERING PLOUGH CORP
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion SVP Fin. - Global Controller acquired 383 shares (option exercise)
- 4 Exercise or conversion EVP & Pres. MMD acquired 552 shares (option exercise)
- 3/A Insider 3/A
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion EVP, Access, Policy & Comms acquired 1,967 shares (option exercise)
- 4 Exercise or conversion Exe V-P & Pres. MMD acquired 2,597 shares (option exercise)
- 4 Exercise or conversion EVP&Pres, Merck Animal Heallth acquired 2,518 shares (option exercise)
- 4 Exercise or conversion EVP,Chief Info&Digital Officer acquired 1,377 shares (option exercise)
- 4 Exercise or conversion SVP Fin. - Global Controller acquired 1,408 shares (option exercise)
- 4 Exercise or conversion Executive VP & President, MRL acquired 4,722 shares (option exercise)
- 4 Exercise or conversion EVP, General Counsel acquired 2,951 shares (option exercise)
- 4 Exercise or conversion EVP, Chief HR Officer acquired 13,435 shares (option exercise)
- 4 Exercise or conversion EVP & CFO acquired 3,935 shares (option exercise)
- 4 Exercise or conversion Chairman, CEO & President acquired 13,300 shares (option exercise)
- 4 Exercise or conversion EVP, Oncology & Int?l acquired 1,377 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 3 of 99 · 1,973 filings